Share on StockTwits
 

Research analysts at BMO Capital Markets boosted their price target on shares of Elizabeth Arden (NASDAQ:RDEN) from $22.00 to $24.00 in a report released on Friday, American Banking & Market News reports. BMO Capital Markets’ target price points to a potential downside of 7.41% from the stock’s previous close.

Shares of Elizabeth Arden (NASDAQ:RDEN) traded up 5.58% during mid-day trading on Friday, hitting $25.92. 798,786 shares of the company’s stock traded hands. Elizabeth Arden has a 52-week low of $23.45 and a 52-week high of $49.47. The stock has a 50-day moving average of $31.47 and a 200-day moving average of $35.95. The company has a market cap of $769.3 million and a price-to-earnings ratio of 18.58.

Elizabeth Arden (NASDAQ:RDEN) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $1.08 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.08. The company had revenue of $418.00 million for the quarter, compared to the consensus estimate of $416.60 million. During the same quarter last year, the company posted $1.58 earnings per share. Elizabeth Arden’s revenue was down 10.6% compared to the same quarter last year. On average, analysts predict that Elizabeth Arden will post $1.46 earnings per share for the current fiscal year.

A number of other analysts have also recently weighed in on RDEN. Analysts at Zacks downgraded shares of Elizabeth Arden from a “neutral” rating to an “underperform” rating in a research note to investors on Tuesday, January 21st. They now have a $26.60 price target on the stock. Separately, analysts at B. Riley cut their price target on shares of Elizabeth Arden from $42.00 to $30.00 in a research note to investors on Tuesday, January 21st. They now have a “neutral” rating on the stock. Finally, analysts at Telsey Advisory Group cut their price target on shares of Elizabeth Arden from $35.00 to $30.00 in a research note to investors on Friday, January 17th. They now have a “not rated” rating on the stock. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $35.95.

Elizabeth Arden, Inc is a beauty products company with a range of portfolio of fragrance, skin care and cosmetics brands.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.